Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis.
about
Recent Advances in Clinical Glycoproteomics of Immunoglobulins (Igs)Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical reviewFc glycans of therapeutic antibodies as critical quality attributesImmune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesMapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous systemA close look at human IgG sialylation and subclass distribution after lectin fractionationA pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines.A monoclonal antibody with anti-D-like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effects.Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.Site specific conjugation of fluoroprobes to the remodeled Fc N-glycans of monoclonal antibodies using mutant glycosyltransferases: application for cell surface antigen detectionAnalytical and Functional Aspects of Antibody Sialylation.Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis.IgG transmitted from allergic mothers decreases allergic sensitization in breastfed offspring.Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies.Different IVIG glycoforms affect in vitro inhibition of anti-ganglioside antibody-mediated complement deposition.N-linked glycoproteomic analysis of formalin-fixed and paraffin-embedded tissuesFunction characterization of a glyco-engineered anti-EGFR monoclonal antibody cetuximab in vitro.Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changesChange in IgG1 Fc N-linked glycosylation in human lung cancer: age- and sex-related diagnostic potential.Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin GIgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis.High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations.Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugatesProduction of α2,6-sialylated IgG1 in CHO cellsComprehensive N-Glycan Profiling of Cetuximab Biosimilar Candidate by NP-HPLC and MALDI-MS.Comparison of the Fc glycosylation of fetal and maternal immunoglobulin GPost-translational modifications in the context of therapeutic proteins.Glycoproteomic analysis of antibodies.Antibody therapeutics: isotype and glycoform selection.Sialylated immunoglobulin G can neutralize influenza virus infection through receptor mimicrySystems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease.Effects of allergic diseases and age on the composition of serum IgG glycome in children.MALDI-TOF-MS reveals differential N-linked plasma- and IgG-glycosylation profiles between mothers and their newborns.A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresisFractionation of Fab glycosylated immunoglobulin G with concanavalin A chromatography unveils new structural properties of the moleculeIgG glycosylation analysis.Monomeric Immunoglobulin A from Plasma Inhibits Human Th17 Responses In Vitro Independent of FcαRI and DC-SIGN.Towards the implementation of quality by design to the production of therapeutic monoclonal antibodies with desired glycosylation patterns.Glycoproteomics and clinical applications.The role of sialic acid as a modulator of the anti-inflammatory activity of IgG.
P2860
Q26752274-86667593-2043-4131-8FC6-59082181463CQ26782025-A5A6CF22-734F-4A3A-AB99-7CDF0FC009FBQ26799266-B4288606-FFB0-4C34-80EB-0D0D15853CA7Q28069362-9C951FB0-7AEA-4B2E-B9BC-4E6179E77BE5Q28075974-46796669-5D49-48F8-8C96-2ED397F1FB87Q28255484-9FE20420-D412-487C-AD79-D5E3DFC851C9Q30368704-961F82FB-BDD5-4510-9D4B-163B70E77BCCQ33420988-779541C0-8023-4B83-944B-8A854BDE745DQ33436829-AE866DE8-21DB-4A6A-A2BE-4CA905FACE11Q33441587-03004ECC-A7BA-45FC-AE33-6663881D1F32Q33903461-3C4745A0-FBF1-4D04-9EF7-4A564A2308FDQ33986960-2386F450-700B-4F1A-954F-3D8B7D1BE42FQ34036447-E44D41D0-0C3D-44E4-9E7D-4B2839C68492Q34190158-E00058B2-42D6-4FCC-BE26-FB32F24585D3Q34258085-F6BE06D5-BB30-443D-82EC-548C2C5D6CE2Q34287959-3BC5E622-11FB-4E62-A075-F468A7FB3827Q34451930-B83F68E7-EFF8-4986-8571-88920DFF7E3DQ34468348-2CD6B28F-05CE-4DCA-81FF-BD6C512EF264Q34772586-63DA7CD5-7435-422A-9C93-507A72EDC923Q35063963-1B43C8DD-5316-4720-862F-EB13D5198618Q35153201-2A1B5C8F-8EE2-4B8D-8E4C-499E57A12208Q35497686-4FA33DCB-D7B7-4429-BF76-5094127C12A1Q35969892-721E3E56-23D7-44EF-B0A7-8C82F00D484FQ36213335-C83F1092-EA3E-402C-82E6-D2DB19CA75C5Q36245448-C3FC5D81-5F54-48B4-B698-B17D6894122FQ36554708-55C8336D-29C0-4676-A9D2-75D7F1965844Q36620451-985743E9-C563-42B6-BD24-93B55533B385Q36742404-ED87BC01-EB60-4176-ABCF-F9AC8581733AQ36922260-030AD83B-E60B-414E-9B68-AF3C2233F75AQ37085836-B4E002BB-54EE-49D8-BBA3-613BE820C330Q37182109-7F40081F-4A62-4B57-9B51-5EFB340DA61FQ37248132-1A16FBE5-2FC9-43E5-BA77-7A027AD513C6Q37281976-1EACF3C0-6A4D-4B13-9F26-BA4C8908F7ECQ37319976-AB94EF6A-5CC1-4074-B015-3D54DA3F8EF4Q37327690-F1D74675-B443-41D2-BA6F-93F871835163Q37391496-CC5EA53E-18A4-4C02-A673-A96F21AC9017Q37698474-5F040316-E2CF-4531-84BA-824B0372746AQ37776217-B839AC0F-6566-4F9E-A94D-EE0011BB106EQ37817273-38E30EFE-9677-457E-9F61-61D8851BA3B8Q37995919-726764CE-84EE-493F-83FC-FEDFA4D69692
P2860
Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Differential glycosylation of ...... ssociated systemic vasculitis.
@en
Differential glycosylation of ...... ssociated systemic vasculitis.
@nl
type
label
Differential glycosylation of ...... ssociated systemic vasculitis.
@en
Differential glycosylation of ...... ssociated systemic vasculitis.
@nl
prefLabel
Differential glycosylation of ...... ssociated systemic vasculitis.
@en
Differential glycosylation of ...... ssociated systemic vasculitis.
@nl
P2093
P1476
Differential glycosylation of ...... associated systemic vasculitis
@en
P2093
C O S Savage
D M Goodall
N Takahashi
R Jefferis
P304
P356
10.1016/J.BBAGEN.2005.11.021
P577
2005-12-27T00:00:00Z